Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Mass Spectrometer Enhances Performance in Protein Analysis

May 2, 2014

Mass Spectrometer Enhances Performance in Protein Analysis

Janssen Pharmaceutical Collaborates with Stiching International Dispensary Association

May 2, 2014

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

Novartis Publishes eBook of Meningococcal Disease Survivors

May 2, 2014

Novartis' eBook features images of meningococcal disease survivors from around the world.

Microscope Enables High-Resolution Materials Analysis

May 2, 2014

Microscope Enables High-Resolution Materials Analysis

Bristol-Myers Squibb Named First on 2014 Best Corporate Citizens List

May 2, 2014

Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.

USP Proposes New Standards for Organic Impurities in Medicines

May 1, 2014

USP releases new and revised standards for organic impurities in medicines for public comment.

Gallus BioPharmaceuticals Enters Agreement with Omni Bio Pharmaceutical

May 1, 2014

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Shire Acquires Fibrotech

May 1, 2014

Shire acquires Fibrotech for $75 million.

Sartorius Stedim Biotech Acquires Majority Stake in AllPure Technologies

Apr 28, 2014

Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here